We at Fullpower-AI® are proud to share our latest peer-reviewed study, published in the Journal of Sleep Medicine: https://doi.org/10.1016/j.sleep.2025.106808
This large-scale U.S. study evaluates home-based, under-mattress devices (the Sleeptracker-AI® platform) for the detection and prevalence of Obstructive Sleep Apnea (OSA) — comparing its accuracy to traditional in-lab polysomnography (PSG).
Key Findings
High Accuracy: Sleeptracker-AI reliably detects moderate to severe OSA, with results comparable to gold-standard lab tests.
Consistency: Strong night-to-night reliability supports continuous monitoring.
Clinical Relevance: Expansion into telemedicine programs can expand early screening and management of OSA.
Why It Matters
Comfort & Accessibility: Patients can be screened at home, increasing adherence and reducing barriers to care.
Cost & Efficiency: Faster, more scalable diagnostics lower healthcare costs and shorten wait times.
Equity & Reach: Brings sleep health to underserved and remote populations.
This work reinforces the transformative role of the Sleeptracker-AI, a non-invasive, continuous, home-based biosensing platform, in improving the early detection and management of sleep-disordered breathing.
At Fullpower-AI, we are committed to advancing science-backed, AI-powered solutions that improve health outcomes worldwide.
About Fullpower-AI®
Fullpower-AI® empowers companies to unlock and maximize actionable insights in real-time, turning them into real-world actions.
Our flagship platforms, KOA™ and Sleeptracker-AI®, continuously process vast streams of biosensing and application-relevant data. By applying advanced data science, predictive AI, and specialized large action-focused generative AI, we aggregate diverse streams of data, analyze into precise, actionable intelligence, and act through connected devices to take real-world actions that drive optimal outcomes. Stanford Medicine and UCSF independently vet our platform.